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ARTICLE
Evidence for a QTL on chromosome 19 influencing
LDL cholesterol levels in the general population
Marian Beekman*,1,12, Bastiaan T Heijmans1,12, Nicholas G Martin2, John B Whitfield3,
Nancy L Pedersen4, Ulf DeFaire5, Harold Snieder6,7, Nico Lakenberg1, H Eka D Suchiman1,
Peter de Knijff8, Rune R Frants8, Gert Jan B van Ommen8, Cornelis Kluft9, George P Vogler10,
Dorret I Boomsma11 and P Eline Slagboom1
1Section of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; 2Queensland Institute
for Medical Research, Brisbane, Australia; 3Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Sydney,
Australia; 4Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden; 5Institute of Environmental
Medicine, Karolinska Institute, Stockholm, Sweden; 6Twin Research & Genetic Epidemiology Unit, St Thomas’ Hospital,
London, UK; 7Georgia Prevention Institute, Medical College of Georgia, Augusta, USA; 8Department of Human and
Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; 9Department of Vascular and Connective
Tissue Research, TNO Prevention and Health, Leiden, The Netherlands; 10Department of Biobehavioral Health, Center
for Developmental and Health Genetics, Pennsylvania State University, University Park, PA, USA; 11Department
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The genetic basis of cardiovascular disease (CVD) with its complex etiology is still largely elusive. Plasma
levels of lipids and apolipoproteins are among the major quantitative risk factors for CVD and are
well-established intermediate traits that may be more accessible to genetic dissection than clinical
CVD end points. Chromosome 19 harbors multiple genes that have been suggested to play a role in lipid
metabolism and previous studies indicated the presence of a quantitative trait locus (QTL) for cholesterol
levels in genetic isolates. To establish the relevance of genetic variation at chromosome 19 for plasma
levels of lipids and apolipoproteins in the general, out-bred Caucasian population, we performed a linkage
study in four independent samples, including adolescent Dutch twins and adult Dutch, Swedish and
Australian twins totaling 493 dizygotic twin pairs. The average spacing of short-tandem-repeat markers
was 6–8 cM. In the three adult twin samples, we found consistent evidence for linkage of chromosome 19
with LDL cholesterol levels (maximum LOD scores of 4.5, 1.7 and 2.1 in the Dutch, Swedish and Australian
sample, respectively); no indication for linkage was observed in the adolescent Dutch twin sample. The
QTL effects in the three adult samples were not significantly different and a simultaneous analysis of the
samples increased the maximum LOD score to 5.7 at 60 cM pter. Bivariate analyses indicated that the
putative LDL-C QTL also contributed to the variance in ApoB levels, consistent with the high genetic
correlation between these phenotypes. Our study provides strong evidence for the presence of a QTL
on chromosome 19 with a major effect on LDL-C plasma levels in outbred Caucasian populations.
European Journal of Human Genetics (2003) 11, 845–850. doi:10.1038/sj.ejhg.5201053
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Introduction
Dissecting the genetic basis of cardiovascular disease (CVD)
is complicated by the etiologic heterogeneity of seemingly
undistinguishable clinical end points. Major quantitative
risk factors for CVD such as cholesterol levels may be more
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accessible to genetic dissection.1 Also, individuals do not
need to be classified as affected or unaffected for these
quantitative variables, which often leads to ambiguous or
uncertain phenotype assignment. Genes described to date
that play a role in lipid metabolism have mainly been
identified in familial lipid disorders, many of which are
monogenic diseases. For example, defects in the genes
encoding the low-density-lipoprotein-receptor (LDLR,
19p13.2)2 and apolipoprotein B (APOB, 2p24)3 are found
to be responsible for the most common forms of familial
hypercholesterolemia, and mutations in the ABC1 gene
(9q31.1), encoding the cholesterol efflux regulatory pro-
tein, induce familial HDL cholesterol deficiency (Tangier’s
disease).4 Although carriers of such mutations may develop
severe disorders of lipid metabolism, these mutations
explain only a minor proportion of the variation in plasma
levels of lipids and apolipoproteins at the level of the
general population.5 The results of twin studies showing
that 50–80% of the population variation in levels of lipids
and apolipoproteins is attributable to genetic factors6,7
thus imply that the majority of the genes determining
these levels are still to be discovered.
Chromosome 19 harbors several genes that have been
suggested to play a role in lipid metabolism including
the LDLR (19p13.2),2 the apolipoprotein E gene (APOE,
19q13.2)8 and other genes from the APOE/C1/C4/C2
cluster,9,10 the insulin-receptor gene (INSR, 19p13.3),11
the hormone-sensitive-lipase gene (LIPE, 19q13.1)12 and
the LDLR-related-protein-type3 gene (LRP3, 19q12).13
Compatible with this wealth of candidate genes, evidence
for linkage with plasma levels of total cholesterol was
found in Pima Indians and with LDL cholesterol levels in
Hutterites.14,15 In contrast to the findings in these genetic
isolates, however, no significant linkage with LDL-C levels
on chromosome 19 was found in genome scans among
outbred Caucasians.16 – 20 To gain insight into the effect of
genetic variation on chromosome 19 on lipid metabolism
in the general, Caucasian population, we performed a
linkage study in four twin samples originating from The




We studied samples of adolescent Dutch twins and adult
Dutch (sample on cardiovascular risk factors), Swedish
(Swedish Adoption/Twin Study of Aging) and Australian
twins (Semi-Structured Assessment for the Genetics of
Alcoholism). The recruitment of the twins and the
measurements of lipid and apolipoprotein levels in the
different samples are described elsewhere.7 In this study
we used 83 dizygotic (DZ) young Dutch twin pairs (aged
13–22 years), 117 DZ adult Dutch twin pairs (aged 34–62
years), 44 DZ Swedish twin pairs (aged 42–81 years) and
249 DZ Australian twin pairs (aged 31–80 years). All
relationships were confirmed with the Graphical Repre-
sentation of Relationship software21 using more than 100
short tandem repeats. Total cholesterol, HDL cholesterol,
apolipoprotein B, apolipoprotein AI, triglycerides and
apolipoprotein E levels were assessed in the plasma.
Concentrations of low-density lipoprotein (LDL) chole-
sterol were calculated according to Friedewald et al.22 If the
triglyceride concentration did exceed 4.52 mmol/l, the
subject obtained a missing value for LDL cholesterol.23
Genotyping
In the four twin pair samples, 12 short tandem repeats with
an average intermarker distance of 8 centiMorgans (cM)
were genotyped (D19S247, D19S1034, D19S394, D19S714,
D19S49, D19S433, D19S47, APOC2, D19S246, D19S180,
D19S210 and D19S254). In the two Dutch samples, four
additional markers were genotyped (D19S391, D19S865,
D19S420, D19S178), resulting in an average spacing of
6 cM in the Dutch. The average heterozygosity for these
markers was estimated at 0.78 and the Marshfield genetic
map (http://research.marshfieldclinic.org/genetics/) was
used.
The Cy5-labeled PCR products were electrophoretically
separated on an automated-fluorescence DNA sequencer,
ALFexpress (Amersham Pharmacia Biotech). Analysis and
assignment of the marker alleles were performed with
Fragment Analyser 1.02 (Amersham Pharmacia Biotech).
To reduce genotyping errors, one known genotype was
present on each gel, 5% of the genotypings were repeated
and two independent individuals performed the allele
calling. SIBMED24 was used to identify unlikely double
recombinants, the occurrence of which may be due to
genotyping errors. After running SIBMED and checking the
raw genotyping data, approximately 0.2% of the total
genotypings appeared to be erroneous. Dependent on the
error, these genotypes were changed in the right genotype
or were set to missing.
Statistical analysis
Allele frequencies were estimated separately for the twin
samples using marker data for all individuals.25 Plasma
levels of triglycerides and apoE showed a skewed distribu-
tion and these values were therefore transformed by
natural logarithm prior to analysis. The full distribution
of multipoint identity-by-descent (IBD) sharing proba-
bilities was estimated every centiMorgan across chromo-
some 19 using Genehunter 2.1.26 Linkage analysis of
quantitative traits was performed with variance compo-
nents analysis using structural equation modeling with
maximum likelihood implemented in the software Mx
1.52d.27 The weighted likelihood approach, which makes
use of the full distribution of IBD-probabilities, with
adjustments for age and sex was used.28 In a four-sample
simultaneous analysis, IBD status for the DZ pairs was
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estimated separately for each of the four samples in
Genehunter 2.126 using population-specific allele frequen-
cies. Mean LDL-C levels, background genetic and non-
shared environmental effects were estimated for each
sample separately. The absolute QTL effects were con-
strained to be equal over the different samples. Hetero-
geneity between the effects of the QTL in the different twin
samples was tested by comparing the model estimating all
parameters for the populations separately with the model
in which the QTL effect was constrained to be equal.
Bivariate analyses29 were performed for correlated plasma
levels of LDL-C and apoB.
Results
The characteristics of the adolescent Dutch and adult
Dutch, Swedish and Australian dizygotic twins totaling 493
pairs are shown in Table 1.
The four twin samples were analyzed using variance
components analyses, which revealed a consistent indica-
tion for linkage with LDL cholesterol (LDL-C) levels
(Table 2). The maximum LOD scores (MLS) were 4.5, 1.7
and 2.1 in adult Dutch, Swedish and Australian twins,
respectively; no linkage was observed in the adolescent
Dutch twins. Lower levels of linkage were also observed for
the LDL-C levels correlated phenotypes total cholesterol
and apoB in the adult populations (Table 2).
As shown in Figure 1, linkage in the adult twins samples
was observed in the same chromosomal region suggesting
that the same QTL may be involved. This was reinforced by
the fact that the QTL effect was not significantly different
in the three adult populations at the positions where the
MLS were observed (P¼0.50, 34 cM pter; P¼ 0.13, 60 cM
pter; P¼0.06, 63 cM pter), whereas the QTL effect was
significantly different in the adolescent Dutch population
(eg P¼0.0001, 60 cM pter). Therefore, the adult popula-
tions were combined in one linkage analysis including 410
dizygotic twin pairs (Figure 1). This analysis increased the
MLS for LDL-C levels to 5.7 at 60 cM pter. Of the twin pairs
that individually contributed more than 0.20 to the MLS,
62% (18/29) were Dutch, 17% (5/29) were Swedish and
21% (6/29) were Australian.
LDL-C and apoB levels are highly correlated phenotypes,
both phenotypically (X0.79) and genetically (X0.79)
(Table 3) indicating that genetic variation influencing
LDL-C levels also influences apoB levels. Nevertheless,
the MLSs were considerably higher for LDL-C levels than
for apoB levels. To gain insight into the effect of the LDL-C
QTL on apoB levels, we performed a bivariate linkage
analysis of the two phenotypes at the position of MLS in
the adult samples. Although the confidence intervals were
wide and the estimates of the QTL effect not always
significant (Table 3), this analysis showed that the putative
QTL explained a considerable proportion of the variance in
apoB levels in addition to that of LDL-C levels.
Discussion
We have studied chromosome 19 for linkage with inter-
mediate lipid phenotypes of cardiovascular disease in
dizygotic twin pairs from the general population of The
Netherlands, Sweden and Australia. In all the adult twin
samples, we found evidence for linkage of chromosome 19
with LDL-C levels with MLS ranging from 1.7 to 4.5. In
spite of a large heritability of LDL cholesterol levels, which
was previously estimated in the adolescent and adult twin
samples between 0.60 and 0.85,7 no indication for linkage
was observed in the adolescent twin sample. This may be
due to partly different effects of genes on lipid levels at
different ages as suggested by Snieder et al30 or to different
gene–environment interaction on lipid levels at different
ages as suggested by Zerba et al31 The size of the QTL effect
on LDL-C levels was not significantly different in the adult
samples and a simultaneous analysis of these adult samples
increased the LOD score to 5.7 at 60 cM from pter. This
constitutes significant linkage according to the Lander–
Table 1 Characteristics of adolescent Dutch and adult Dutch, Swedish and Australian dizygotic twin samples
Adolescent Adult
Netherlands Netherlands Sweden Australia
Phenotype (n¼166) (n¼234) (n¼88) (n¼498)
Men, % 49.4 48.7 59.1 35.7
Age, years – mean (range) 17 (13–22) 44 (34–59) 65 (42–81) 44 (31–80)
Inter-marker distance, cM – mean (SD) 6.29 (4.18) 6.29 (4.18) 8.38 (4.02) 8.38 (4.02)
Body mass index (kg/m2) 20.28 (2.21) 24.64 (3.06) 25.21 (3.07) 25.44 (5.19)
LDL-C, mmol/l – mean (SD) 2.56 (0.65) 3.63 (0.99) 4.26 (1.07) 3.37 (1.07)
ApoB, g/l – mean (SD) 0.79 (0.17) 1.21 (0.35) 1.04 (0.21) 0.97 (0.28)
Total cholesterol, mmol/l – mean (SD) 4.15 (0.70) 5.39 (1.06) 6.50 (1.11) 5.64 (1.20)
HDL-C, mmol/l – mean (SD) 1.28 (0.26) 1.22 (0.38) 1.47 (0.34) 1.46 (0.41)
ApoAI, g/l – mean (SD) 1.38 (0.20) 1.67 (0.43) 1.39 (0.30) 1.44 (0.27)
Triglycerides, mmol/l – mean (SD) 0.68 (0.30) 1.22 (0.71) 1.62 (0.87) 1.90 (1.69)
ApoE, mg/dl – mean (SD) 6.59 (2.39) 2.54 (1.02) F (F) 4.18 (1.88)
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Kruglyak criteria.32 A bivariate analysis indicates that
the QTL also influences apoB levels as is consistent
with the fact that the majority of apoB protein circulates
as a constituent of LDL particles. Our linkage study thus
emphasizes the relevance of genetic variation on chromo-
some 19 for cardiovascular risk in the general population.
Previous studies reported evidence for linkage of chro-
mosome 19 with total cholesterol levels (MLS¼3.89) and
LDL-C levels (Genome-wide P-value¼ 0.035) in Pima
Indians14 and Hutterites,15 respectively. Our study extends
these findings in genetic isolates to the general, Caucasian
population. A further inspection of other genome scans in
Caucasians from the general population (Table 4) shows
that, although the reported LOD scores for chromosome 19
are not significant, they are compatible with our findings.
Linkage with LDL1-C levels in the San Antonio Heart Study
(LOD¼ 2.26) and with LDL2-C levels (LOD¼1.86),33 and
linkage with total cholesterol levels in the Rochester
Family Heart Study (LOD¼1.14).34 No suggestion for
linkage with total cholesterol or LDL-C levels, however,
was found in selected samples of myocardial infarction
patients, type II diabetes patients and patients with familial
combined hyperlipidemia.16 – 20 The LDL-C QTL on chro-
mosome 19 thus constitutes one of the most replicated
result from linkage studies, virtually ruling out the
possibility that it is a false-positive observation.
The region in which we and other groups (Figure 1,
Table 4) found evidence for linkage is broad, as is a general
characteristic of results from twin and sib pair studies. QTL
mapping in Drosophila melanogaster and Saccharomyces
cerevisiae demonstrated that linkage results at a broad
chromosomal region may be caused by several polymorph-
isms with a relatively small effect, which could be
interpreted as one gene with a major effect.35,36 Possibly,
several loci on chromosome 19 are influencing LDL
cholesterol levels and perhaps different loci play major
roles in Australian and European LDL cholesterol levels,
which might explain the different locations of the MLS.
However, the overall effect size of these loci is the not
significantly different in Dutch, Swedish and Australians.
The main candidates for underlying the LDL-C QTL on
chromosome 19 (Table 4) are the APOE/C1/C4/C2 gene
cluster and the LDLR and LRP3 gene loci. Apolipoprotein E
is the major constituent of chylomicrons, VLDL and IDL
particles and serves as ligand for the LDLR. When VLDL
and IDL are not efficiently removed from the circulation by
the LDLR, LDL particles will accumulate. The LDLR is also
known to play an important role in the clearance of apoB-
carrying-lipoproteins by the liver.2,37 Apolipoprotein C1 is
a constituent of VLDL and HDL particles. It inhibits the
lipoprotein lipase (LPL)-mediated hydrolysis of the trigly-
cerides from VLDL, which leads to lower levels of LDL-C.38
ApoC2 has the opposite effect on LDL-C levels, since it is
an activator of LPL.39 Although the function of apoC4 is
unknown, there are some indications that it might play a
role in lipid metabolism.10,40 The LRP3 is a family member
of the LDLR. It is also expressed in the liver and it binds
apoE-containing particles. The function of the LRP3
Table 2 Maximum LOD scores observed at chromosome
19 for lipid and apolipoprotein levels in adolescent Dutch
and adult Dutch, Swedish and Australian DZ twins
Phenotype Position from pter Max LOD score
LDL cholesterol
Adolescent Netherlands 98 0.5
Adult Netherlands 60 4.5
Adult Sweden 63 1.7
Adult Australia 34 2.1
ApoB
Adolescent Netherlands 98 0.3
Adult Netherlands 48 1.0
Adult Sweden 70 1.6
Adult Australia 80 0.5
Total cholesterol
Adolescent Netherlands 53 0.2
Adult Netherlands 60 2.3
Adult Sweden 63 1.3
Adult Australia 30 1.7
HDL cholesterol
Adolescent Netherlands 67 0.1
Adult Netherlands 32 0.5
Adult Sweden 34 0.2
Adult Australia 57 1.2
ApoA1
Adolescent Netherlands 0 0.1
Adult Netherlands 34 0.2
Adult Sweden 36 1.0
Adult Australia 51 1.5
Triglycerides
Adolescent Netherlands 52 1.2
Adult Netherlands 45 0.6
Adult Sweden 63 0.1
Adult Australia 63 0.2
ApoE
Adolescent Netherlands 69 1.0
Adult Netherlands 63 2.8
Adult Sweden F F
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Figure 1 Linkage of LDL cholesterol levels with chromo-
some 19 in adult Dutch (green line), Swedish (black line)
and Australian (blue line) twins in separate analyses and a
combined analysis (red line).
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remains unclear, but as a family member of LDLR a role in
lipid metabolism is assumed.13 INSR and LIPE are candi-
dates for influencing triglyceride levels, but not for LDL-C
levels.11,12 Near the LDLR locus, the ATHS locus has been
mapped involved in atherogenic lipoprotein phenotype
pattern B, which is characterized by small, dense LDL
particles, increased levels of triglycerides and decreased
levels of HDL-C.41 Since we have no indication for linkage
with levels of triglycerides and HDL-C, we assume that the
ATHS locus is a different locus than our LDL-C QTL.
In conclusion, we report strong and significant evidence
for the presence of genetic variation at chromosome 19
with a major effect on LDL-C plasma levels in outbred
Caucasian populations. Since high LDL-C level is a major
risk factor for CVD, this finding may significantly con-
tribute to disentangling the complex architecture of CVD.
Candidate gene screening and the recently developed
method for the combined analysis of linkage and associa-
tion42,43 may reveal the genetic variation underlying the
QTL.
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